In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.

It is crucial to understand the distribution of embolic agents inside target liver during and after the hepatic portal vein embolization (PVE) procedure. For a long time, the problem has not been well solved due to the radiolucency of embolic agents and the resolution limitation of conventional radi...

Full description

Bibliographic Details
Main Authors: Rongbiao Tang, Wei Huang, Fuhua Yan, Yong Lu, Wei-Min Chai, Guo-Yuan Yang, Ke-Min Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3851775?pdf=render
id doaj-a6847b1f1bcd4f2bbfde34bbe34516ad
record_format Article
spelling doaj-a6847b1f1bcd4f2bbfde34bbe34516ad2020-11-25T01:23:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8091910.1371/journal.pone.0080919In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.Rongbiao TangWei HuangFuhua YanYong LuWei-Min ChaiGuo-Yuan YangKe-Min ChenIt is crucial to understand the distribution of embolic agents inside target liver during and after the hepatic portal vein embolization (PVE) procedure. For a long time, the problem has not been well solved due to the radiolucency of embolic agents and the resolution limitation of conventional radiography. In this study, we first reported use of fluorescent carboxyl microspheres (FCM) as radiolucent embolic agents for embolizing hepatic portal veins. The fluorescent characteristic of FCM could help to determine their approximate location easily. Additionally, the microspheres were found to be fairly good embolizing agents for PVE. After the livers were excised and fixed, they were imaged by in-line phase contrast imaging (PCI), which greatly improved the detection of the radiolucent embolic agents as compared to absorption contrast imaging (ACI). The preliminary study has for the first time shown that PCI has great potential in the pre-clinical investigation of PVE with radiolucent embolic agents.http://europepmc.org/articles/PMC3851775?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Rongbiao Tang
Wei Huang
Fuhua Yan
Yong Lu
Wei-Min Chai
Guo-Yuan Yang
Ke-Min Chen
spellingShingle Rongbiao Tang
Wei Huang
Fuhua Yan
Yong Lu
Wei-Min Chai
Guo-Yuan Yang
Ke-Min Chen
In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
PLoS ONE
author_facet Rongbiao Tang
Wei Huang
Fuhua Yan
Yong Lu
Wei-Min Chai
Guo-Yuan Yang
Ke-Min Chen
author_sort Rongbiao Tang
title In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
title_short In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
title_full In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
title_fullStr In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
title_full_unstemmed In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
title_sort in-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description It is crucial to understand the distribution of embolic agents inside target liver during and after the hepatic portal vein embolization (PVE) procedure. For a long time, the problem has not been well solved due to the radiolucency of embolic agents and the resolution limitation of conventional radiography. In this study, we first reported use of fluorescent carboxyl microspheres (FCM) as radiolucent embolic agents for embolizing hepatic portal veins. The fluorescent characteristic of FCM could help to determine their approximate location easily. Additionally, the microspheres were found to be fairly good embolizing agents for PVE. After the livers were excised and fixed, they were imaged by in-line phase contrast imaging (PCI), which greatly improved the detection of the radiolucent embolic agents as compared to absorption contrast imaging (ACI). The preliminary study has for the first time shown that PCI has great potential in the pre-clinical investigation of PVE with radiolucent embolic agents.
url http://europepmc.org/articles/PMC3851775?pdf=render
work_keys_str_mv AT rongbiaotang inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT weihuang inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT fuhuayan inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT yonglu inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT weiminchai inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT guoyuanyang inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
AT keminchen inlinephasecontrastimagingofhepaticportalveinembolizationwithradiolucentembolicagentsinmiceapreliminarystudy
_version_ 1725119874663972864